• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOzempic

Ozempic

Page 4 of 9
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
FinancePfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
Ozempic goes from threat to opportunity for packaged-food makers
HealthOzempic goes from threat to opportunity for packaged-food makers
By Deena Shanker and BloombergOctober 2, 2024
A person holds up a box of Ozempic.
HealthOzempic may help manage opioid addiction: study
By Naomi Kresge and BloombergSeptember 25, 2024
Tesla CEO Elon Musk attends the 10th Annual Breakthrough Prize Ceremony at Academy Museum of Motion Pictures.
HealthElon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic
By Christiaan HetznerSeptember 25, 2024
Sen. Bernie Sanders is seen pointing and speaking at the opening of a Senate committee hearing.
PoliticsBernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By Madison Muller, Naomi Kresge, Riley Griffin and BloombergSeptember 24, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
HealthNovo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By Ryan HoggSeptember 24, 2024
Photo of Anne Wojcicki
SuccessEvery single member of the board just resigned from DNA tester 23andMe
By Jane ThierSeptember 18, 2024
A doctor holds a package of the drug Ozempic. The logo is clearly visible and there is a visual of the product on the box.
FinanceOzempic ‘very likely’ to have price slashed in US government negotiations
By Gerry Smith, Madison Muller and BloombergSeptember 17, 2024
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
HealthRoche stock is falling after report its Wegovy challenger is causing patients to vomit
By Naomi Kresge and BloombergSeptember 12, 2024
Ozempic maker has developed a pill that can cause weight loss of up to 13% in three months
HealthOzempic maker has developed a pill that can cause weight loss of up to 13% in three months
By Chris MorrisSeptember 11, 2024
A person sifts through a rack of clothing.
RetailSecondhand luxury fashion thrives as Ozempic users purge their closets
By Sasha RogelbergAugust 29, 2024
A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023.
HealthOzempic linked to suicidal thoughts in new study
By Ani FreedmanAugust 22, 2024
Steve Cahillane wearing a suit and bowtie speaks behind a glass podium.
RetailThe Mars-Kellanova merger bolsters them against 2 big threats—inflation and Ozempic
By Sasha RogelbergAugust 14, 2024
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
HealthExclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By Alexa MikhailAugust 14, 2024
Here’s the real reason Ozempic-like weight-loss drugs are so popular
CommentaryHere’s the real reason Ozempic-like weight-loss drugs are so popular
By Bill NovelliAugust 12, 2024
1
  • 2
  • 3
  • 4
  • 5
  • 6
...9
Most Popular
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Personal Finance
Current price of gold as of April 1, 2026placeholder alt text
By Fortune EditorsApril 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.